CMS PEPTIDES PATENT HOLDING COMPANY LTD has a total of 23 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Australia, EPO (European Patent Office) and New Zealand. Its main competitors in its focus markets pharmaceuticals and biotechnology are CMS PEPTIDES PATENT HOLDING CO, FUNG SEK CHUNG and ASTERION LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | New Zealand | 3 | |
#4 | Taiwan | 3 | |
#5 | Malaysia | 2 | |
#6 | Poland | 2 | |
#7 | Hong Kong | 1 | |
#8 | Russian Federation | 1 | |
#9 | Saudi Arabia | 1 | |
#10 | Singapore | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Wong Wai Ming | 20 |
#2 | Lam Kong | 17 |
#3 | Ming Wong Wai | 3 |
#4 | Kong Lam | 3 |
#5 | Gang Lin | 1 |
#6 | Lin Gang | 1 |
Publication | Filing date | Title |
---|---|---|
AU2007211899A1 | Biologically active peptides | |
AU2006276083A1 | Novel biologically active peptides and their new uses | |
TW200538151A | Biologically active peptide vapeehptllteaplnpk der | |
TW200503748A | Biologically active peptide comprising tyrosyl-seryl-valine (ysv) | |
SG185137A1 | Biologically active peptides | |
TW200844232A | Biologically active peptides (4) |